|
Jul 24
|
Is GSK plc's (LON:GSK) 27% ROE Better Than Average?
|
|
Jul 23
|
Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports
|
|
Jul 23
|
Epilepsy Drugs Market Growth Analysis, Forecast Trends and Outlook Report 2025-2034 | Demand for Generic Epilepsy Drugs Rises as Patent Expirations Fuel Market Growth
|
|
Jul 21
|
Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
|
|
Jul 21
|
Oral Care Market Analysis Report 2025-2032 | Emergence of Electric Toothbrushes, Introduction of Skincare-Inspired Oral Care Products, and Integration of AI in Toothbrushes
|
|
Jul 19
|
Warren Buffett says this book changed his life forever. Here's the real key to long-term gains
|
|
Jul 18
|
BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510
|
|
Jul 18
|
Global Stocks Recap: Alibaba, Saab, Burberry, GSK
|
|
Jul 18
|
Top Midday Stories: Netflix Shares Fall Despite Earnings Beat; Chevron Completes Acquisition of Hess After Winning Legal Dispute With Exxon
|
|
Jul 18
|
FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
|
|
Jul 18
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Jul 18
|
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Strong Economic Data
|
|
Jul 18
|
GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning
|
|
Jul 18
|
GSK falls as blood cancer drug likely headed for US rejection
|
|
Jul 17
|
FDA Committee Votes Against GSK Blood Cancer Drug Blenrep
|
|
Jul 17
|
GSK stock falls after FDA panel rejects blood cancer drug Blenrep
|
|
Jul 17
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Jul 17
|
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
|
|
Jul 16
|
Trump threatens tariffs on medicines within weeks
|
|
Jul 15
|
Merck Starts Phase III Studies on Once-Monthly Pill for HIV Prevention
|